Asset Details
Do you wish to reserve the book?
A Complication-Free Course Ensures a Survival Advantage in Patients after Regional Therapy for Metastatic Colorectal Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Complication-Free Course Ensures a Survival Advantage in Patients after Regional Therapy for Metastatic Colorectal Cancer
Do you wish to request the book?
A Complication-Free Course Ensures a Survival Advantage in Patients after Regional Therapy for Metastatic Colorectal Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Complication-Free Course Ensures a Survival Advantage in Patients after Regional Therapy for Metastatic Colorectal Cancer
2006
Overview
Hepatic artery infusional (HAI) chemotherapy has been shown to favorably impact outcome in patients with metastatic colorectal cancer, but complications often preclude complete treatment. The purpose of this study was to determine whether HAI complications impact survival in these patients. Patients undergoing HAI pump placement at our institution from September 2001 to July 2004 were separated into terciles based on the number of treatments completed: ≤1 (none), 2 to 4 (partial), and ≥5 (complete). Complications relating to pump placement or treatment were recorded for each and their impact on survival was determined. Kaplan-Meier survival in 15 patients receiving no treatment was significantly shorter than 7 patients completing therapy (P = 0.02). Thirty-three per cent of patients receiving no therapy were alive at 26 months, whereas 63 per cent of partially and 86 per cent of completely treated patients were alive at 32 and 30 months, respectively. Patients receiving no treatment had more overall complications (80%) and significantly (P < 0.05) more pump-related complications (60%) than those completing therapy (43% and 0%, respectively). Cox regression revealed a significant correlation to gender (hazard ratio, 3.9), tumor size (hazard ratio, 1.17), and carcinoembryonic antigen level (hazard ratio, 1.02) to survival. Patients receiving complete HAI treatment survive longer than those receiving no treatment. Potentially preventable pump-related complications not only impacted the patients’ ability to continue therapy, but survival times as well.
Publisher
Southeastern Surgical Congress,SAGE PUBLICATIONS, INC
Subject
/ Antineoplastic Agents - administration & dosage
/ Antineoplastic Agents - adverse effects
/ Biological and medical sciences
/ Colorectal Neoplasms - pathology
/ Female
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Humans
/ Infusion Pumps, Implantable - adverse effects
/ Male
/ Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
/ Tumors
